Literature DB >> 7496929

Neutralizing antibody immune response in children with primary and secondary rotavirus infections.

C F Arias1, S López, J D Mascarenhas, P Romero, P Cano, Y B Gabbay, R B de Freitas, A C Linhares.   

Abstract

We have characterized the neutralizing antibody immune response to six human rotavirus serotypes (G1 to G4, G8, and G9) in Brazilian children with primary and secondary rotavirus infections and correlated the response with the G serotype of the infecting rotavirus strain. Twenty-five children were studied: 17 had a single rotavirus infection, 4 were reinfected once, and 4 experienced three infections. Two of the reinfections were by non-group A rotaviruses. Among the 25 primary infections, we observed homotypic as well as heterotypic responses; the serotype G1 viruses, which accounted for 13 of these infections, induced mostly a homotypic response, while infections by serotype G2 and G4 viruses induced, in addition to the homotypic, a heterotypic response directed primarily to serotype G1. Two of the primary infections induced heterotypic antibodies to 69M, a serotype G8 virus that by RNA electrophoresis analysis was found not to circulate in the population during the time of the study. The specificity of the neutralizing antibody immune response induced by a virus of a given serotype was the same in primary as well as secondary infections. These results indicate that the heterotypic immune response induced in a primary rotavirus infection is an intrinsic property of the virus strain, and although there seem to be general patterns of serotype-specific seroconversion, these may vary from serotype to serotype and from strain to strain within a serotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496929      PMCID: PMC368202          DOI: 10.1128/cdli.1.1.89-94.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  38 in total

1.  Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

Authors:  P A Offit; R D Shaw; H B Greenberg
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.

Authors:  K Taniguchi; S Urasawa; T Urasawa
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

3.  A candidate for a new serotype of human rotavirus.

Authors:  S Matsuno; A Hasegawa; A Mukoyama; S Inouye
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity.

Authors:  C F Arias; M Lizano; S López
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Rotavirus isolate WI61 representing a presumptive new human serotype.

Authors:  H F Clark; Y Hoshino; L M Bell; J Groff; G Hess; P Bachman; P A Offit
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus.

Authors:  F I Puerto; L Padilla-Noriega; A Zamora-Chávez; A Briceño; M Puerto; C F Arias
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation.

Authors:  J Flores; K Midthun; Y Hoshino; K Green; M Gorziglia; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  Diverse serologic response to rotavirus infection of infants in a single epidemic.

Authors:  H F Clark; K T Dolan; P Horton-Slight; J Palmer; S A Plotkin
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

9.  Antigenic characterization and ELISA detection of adult diarrhea rotaviruses.

Authors:  S Nakata; M K Estes; D Y Graham; R Loosle; H Tao; S H Wang; L J Saif; J L Melnick
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

10.  Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

Authors:  S Chiba; T Yokoyama; S Nakata; Y Morita; T Urasawa; K Taniguchi; S Urasawa; T Nakao
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

View more
  5 in total

1.  Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.

Authors:  Daniel E Velasquez; Baoming Jiang
Journal:  Hum Vaccin Immunother       Date:  2019-06-13       Impact factor: 3.452

2.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers.

Authors:  Pratibha G Ray; Shobhana D Kelkar
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains.

Authors:  J F Contreras; G E Menchaca; L Padilla-Noriega; R S Tamez; H B Greenberg; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 5.  Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.

Authors:  E Clarke; U Desselberger
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.